President, Research & Development, Takeda Pharmaceutical
Verified interview transcripts, podcast appearances, and direct quotes from Andrew Plump, President, Research & Development at Takeda Pharmaceutical. AI-verified speaker identity with full-text searchable transcripts.
“Culture is really hard to change. And the only way that you could you can get in there and and and and move you can't change it overnight, but you can move it is by deeply understanding the cultural context that you're within.”
“I think the issues now in cardiovascular disease are around overall health care. It's a little bit less around novel therapeutics, especially in some of the primary indications. And then heart failure. That's the big that's the big open space right now.”
“I've been very opportunistic. I've never really ever had a goal. I've just tracked and followed my heart and things have come my way. I've learned over time that my demographics being a white male trained as I have been make that easier for me than for other people. So, I do think it's you do need to have goals and you...”
“We're really serious about culture. Um I hope every scientific environment is. We describe it. We talk about it. Um when I started at NBER brave, open and kind. Brave, open and kind. every town hall. Brave, open, and kind. Every person we hire, are they brave? Are they open? Are they kind? Um, and then you have to walk...”
“I think that if we don't leave this pandemic with an entirely different reputation than the one that we've come in with, then we failed as an industry. We have a huge opportunity in front of us to do good and to change our reputation.”
“I've always thought that I've been open-minded, inclusive, and equitable, but I also realize that I come from a very privileged white male background. And it's only been recently that I've realized, I mean epiphany really is the right word, that I've realized how different my experiences are relative to that of an aspi...”
“as an R&D head in our industry the spotlight is often on us but it's not to thank us for achievements it's typically to either blame us or to fire us that's kind of what happens to us and so as an R&D head in our industry this is a really special moment.”
“we've made huge strides in really evolving a Japanese national company to a truly multinational company and the statistics speak to it in for the company broadly but also for R&D we were 10% of our company was in Boston now of our R&D organization was in Boston now almost 75% is in Boston our R&D budgets double the num...”
“Unfortunately we've done patients a disservice by not recognizing exactly what you said the need to study our medicines in diverse populations and actually parenthetically we've done ourselves a disservice because there are a lot of patients in diverse marginalized populations that could be enrolled in our trials and s...”
“Unfortunately there are provisions in IRA that will limit innovation and that will prevent our ability from actually going after cures and so we have to work better together to ensure that we're working towards the same common goal which is to treat and ultimately cure disease.”
“We live today in just a remarkable world... we've named our summit from over the past couple of years and it remains this year from n of 1 to n of a billion and it's meant to signify the great innovation that we're seeing in our industry innovation that's taking us to the point where we can make therapies tailored to e...”
“We were both incredibly skilled and the work that came out of so many companies the collective collaborative efforts of industry academia governments and not-for-profits was truly unprecedented. We were also lucky let's be realistic we were lucky we knew that this virus was coming we weren't prepared as we should have...”
“when historians look back at the 21st century they will define this as the golden era of health care what we can do today is absolutely amazing it's amazing it's amazing that we're able to unravel the complexity of nature”
“we have to think every time we develop a medicine that that medicine is going to be applicable to patients everywhere across the world and that's critical if you're interested in innovating we have to harmonize it right now the complexities that exist across different ecosystems this is very important as you're thinkin...”
“we're seeing an explosion of our understanding of human disease and we're seeing an explosion of modalities cell gene therapies that offer transformative and even curative potential to patients”
Andy Plump discusses his journey from a postdoc at UCSF to a leading roles in pharmaceutical research. Andy, who joined Merck ...
Ep93: Jay Bradner of Novartis & Andy Plump of Takeda on Mentoring Young Scientists.
Honoring Dr. Andrew Plump, President of R&D, Takeda with the Distinguished Service Award for his vision and longstanding ...
This episode is in partnership with MIT Sloan Healthcare and BioInnovations Conference ...
This discussion features Seema Kumar, Cure. and Andy Plump, MD, PhD, Takeda. It followed the Opening “Big Think” Plenary ...
Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals.
Watch Mr. Andrew Plump - President, R&D, Takeda Pharmaceutical Company sharing his experience at the 1st Global Innovation ...
Opening Address by Andrew Plump, Chair and Emcee during USAIC's 14th annual BioPharma & Healthcare Summit, September ...
Closing Remarks by Andrew Plump at USAIC's 14th annual BioPharma & Healthcare Summit. Participants: Andrew Plump, Chris ...
Sign in to search the full transcript archive, filter by topic, and access every quote from Andrew Plump.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →